Range
13.25 - 13.91
Vol / Avg.
50.6K/18.7K
Div / Yield
-
52 Wk
6.79 - 14.98
Mkt Cap
58.5M
Payout Ratio
-
Open
13.25
P/E
-
EPS
-0.66
Shares
4.3M
Outstanding
4.3M
Total Float
-
Benzinga - May 13, 2021, 11:41AM
Benzinga - May 11, 2021, 4:46PM
Benzinga - May 11, 2021, 4:30PM
Benzinga - Apr 6, 2021, 6:22AM
Benzinga - Apr 5, 2021, 4:02PM
Benzinga - Mar 31, 2021, 4:03PM
Benzinga - Mar 4, 2021, 4:24PM
Benzinga - Feb 9, 2021, 11:30AM
Benzinga - Feb 8, 2021, 4:01PM
Benzinga - Jan 11, 2021, 4:10PM
Benzinga - Dec 15, 2020, 6:44AM
Benzinga - Dec 14, 2020, 4:13PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.710-0.660 0.0500
REV5.290M6.387M1.097M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OPNTOpiant Pharmaceuticals1.96%58.5M

Opiant Pharmaceuticals Frequently Asked Questions

Q

How do I buy Opiant Pharmaceuticals (OPNT) stock?

A

You can purchase shares of Opiant Pharmaceuticals (NASDAQ: OPNT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Opiant Pharmaceuticals's (OPNT) competitors?

A

Other companies in Opiant Pharmaceuticals’s space includes: Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX), Cumberland (NASDAQ:CPIX), Ocuphire Pharma (NASDAQ:OCUP) and Lipocine (NASDAQ:LPCN).

Q

What is the target price for Opiant Pharmaceuticals (OPNT) stock?

A

The latest price target for Opiant Pharmaceuticals (NASDAQ: OPNT) was reported by Cantor Fitzgerald on September 28, 2018. The analyst firm set a price target for 42.00 expecting OPNT to rise to within 12 months (a possible 211.11% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Opiant Pharmaceuticals (OPNT)?

A

The stock price for Opiant Pharmaceuticals (NASDAQ: OPNT) is $13.5 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Opiant Pharmaceuticals (OPNT) pay a dividend?

A

There are no upcoming dividends for Opiant Pharmaceuticals.

Q

When is Opiant Pharmaceuticals (NASDAQ:OPNT) reporting earnings?

A
Opiant Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Opiant Pharmaceuticals (OPNT) going to split?

A

There is no upcoming split for Opiant Pharmaceuticals.

Q

What sector and industry does Opiant Pharmaceuticals (OPNT) operate in?

A

Opiant Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.